Spero Therapeutics inks Jefferies at-the-market equity distribution deal for up to $100 million

Reuters2026/08/28 21:27

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Spero Therapeutics entered an Open Market Sale Agreement with Jefferies for an at-the-market common stock offering.
Planned sales sized up to USD 100 million under a universal shelf registration statement that is not yet effective.
Jefferies to act as sales agent using commercially reasonable efforts; fee up to 3% of gross proceeds.
Company terminated its prior Cantor Fitzgerald controlled equity offering agreement; no shares sold under that program in 2024 or 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-374788), on August 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Spero Therapeutics inks Jefferies at-the-market equity distribution deal for up to $100 million

You may also like

Crypto prices